Using High-Sensitivity Cardiac Troponin T for Acute Cardiac Care

American Journal of Medicine

Volumn 130, Issue 12, 2017, Pages 1358-1365.e1

  Sandoval, Yader ^a   Jaffe, Allan S ^a  

^a MAYO CLINIC   (United States)

Author keywords

High sensitivity troponin T; Myocardial infarction

Indexed keywords

TROPONIN T;

ACUTE HEART INFARCTION; CARDIOLOGY; EMERGENCY CARE; EMERGENCY MEDICINE; FALSE POSITIVE RESULT; HEALTH CARE PLANNING; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; BLOOD; BLOOD EXAMINATION; DECISION TREE; FEMALE; INTENSIVE CARE; MALE; SENSITIVITY AND SPECIFICITY; STANDARDS;

CRITICAL CARE; DECISION TREES; FEMALE; HEMATOLOGIC TESTS; HUMANS; MALE; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 85029710685     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2017.07.033     Document Type: Review

References (40)

1. Hamm, C.W., Bassand, J.P., Agewall, S., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2999–3054.
2. Sandoval, Y., Smith, S.W., Apple, F.S., Present and future of cardiac troponin in clinical practice: a paradigm shift to high-sensitivity assays. Am J Med 129 (2016), 354–365.
3. Korley, F.K., Jaffe, A.S., Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol 61 (2013), 1753–1758.
4. Elecsys troponin T gen 5 STAT immunoassay FDA decision summary. Available at: https://www.accessdata.fda.gov/cdrh_docs/reviews/K162895.pdf. (Accessed 2 July 2017)
5. Apple, F.S., Sandoval, Y., Jaffe, A.S., Ordonez-Llanos, J., IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 63 (2017), 73–81.
6. Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A.S., Katus, H.A., Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56 (2010), 254–261.
7. Saenger, A.K., Beyrau, R., Braun, S., et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 412 (2011), 748–754.
8. Apple, F.S., Jaffe, A.S., Collinson, P., et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 48 (2015), 201–203.
9. Apple, F.S., Ler, R., Murakami, M.M., Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58 (2012), 1574–1581.
10. Kimenai, D.M., Henry, R.M., van der Kallen, C.J., et al. Direct comparison of clinical decision limits for cardiac troponin T and I. Heart 102 (2016), 610–616.
11. Apple, F.S., Sandoval, Y., Jaffe, A.S., In reply. Clin Chem 63 (2017), 1167–1170.
12. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60 (2012), 1581–1598.
13. Roffi, M., Patrono, C., Collet, J.P., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37 (2016), 267–315.
14. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64 (2014), e139–e228.
15. Sandoval, Y., Apple, F.S., The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem 60 (2014), 455–462.
16. Collinson, P.O., Heung, Y.M., Gaze, D., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 58 (2012), 219–225.
17. Mair J., Lindahl B., Müller C., et al. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. doi:10.1177/2048872617708973.
18. Pickering, J.W., Than, M.P., Cullen, L., et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med 166 (2017), 715–724.
19. Shah, A.S., Anand, A., Sandoval, Y., et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 386 (2015), 2481–2488.
20. McRae A.D., Innes G., Graham M., et al. Undetectable concentrations of an FDA-approved high-sensitivity cardiac troponin T assay to rule out acute myocardial infarction at emergency department arrival. Acad Emerg Med. doi:10.1111/acem.13229.
21. Than, M., Herbert, M., Flaws, D., et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey. Int J Cardiol 166 (2013), 752–754.
22. Kavsak, P.A., Clark, L., Jaffe, A.S., Effect of repeat measurements of high-sensitivity cardiac troponin on the same sample using the European Society of Cardiology 0-hour/1-hour or 2-hour algorithms for early rule-out and rule-in for myocardial infarction. Clin Chem 63 (2017), 1163–1165.
23. Reichlin, T., Schinder, C., Drexler, B., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 10:172 (2012), 1211–1218.
24. Reichlin, T., Twerenbold, R., Wildi, K., et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ 187 (2015), E243–E252.
25. Mueller, C., Giannitsis, E., Christ, M., et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 68 (2016), 76–87.
26. Jaffe, A.S., White, H.D., Ruling-in myocardial injury and ruling out myocardial infarction with the European Society of Cardiology (ESC) 1-hour algorithm. Circulation 134:20 (2016), 1542–1545.
27. Crea, F., Jaffe, A.S., Collinson, P.O., et al. Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?. Eur Heart J 37 (2016), 3316–3323.
28. Wildi, K., Cullen, L., Twerenbold, R., et al. Direct comparison of 2 rule-out strategies for acute myocardial infarction: 2-h accelerated diagnostic protocol vs 2-h algorithm. Clin Chem 63 (2017), 1227–1236.
29. Reichlin, T., Cullen, L., Parsonage, W.A., et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med 128 (2015), 369–379.
30. Sandoval Y., Apple F.S., Smith S.W. High-sensitivity cardiac troponin assays and unstable angina. Eur Heart J Acute Cardiovasc Care. doi: 10.1177/2048872616658591.
31. Reichlin, T., Twerenbold, R., Reiter, M., et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 125 (2012), 1205–1213.
32. Lee, G., Twerenbold, R., Tanglay, Y., et al. Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia. Am Heart J 173 (2016), 8–17.
33. Januzzi, J.L., Sharma, U., Zakroysky, P., et al. Sensitive troponin assays in patients with suspected acute coronary syndrome: results from the multicenter rule out myocardial infarction using computed assisted tomography II trial. Am Heart J 169 (2015), 572–578.
34. Jaffe, A.S., Moeckel, M., Giannitsis, E., et al. In search for the Holy Grail: suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care 3 (2014), 313–316.
35. Bjurman, C., Larsson, M., Johanson, P., et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 62 (2013), 1231–1238.
36. Sandoval, Y., Thygesen, K., Myocardial infarction type 2 and myocardial injury. Clin Chem 63 (2017), 101–107.
37. Hassan, H.C., Howlin, K., Jefferys, A., et al. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 60 (2014), 389–398.
38. Jhund, P.S., Claggett, B.L., Voors, A.A., et al. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail 7 (2014), 953–959.
39. Melki, D., Lugnegård, J., Alfredsson, J., et al. Implications of introducing high-sensitivity cardiac troponin T into clinical practice: data from the SWEDEHEART registry. J Am Coll Cardiol 65 (2015), 1655–1664.
40. Twerenbold, R., Jaeger, C., Rubini Gimenez, M., et al. Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. Eur Heart J 37 (2016), 3324–3332.